rs437168

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004646.4(NPHS1):​c.2289C>T​(p.Val763=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0635 in 1,613,890 control chromosomes in the GnomAD database, including 10,206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 4540 hom., cov: 32)
Exomes 𝑓: 0.053 ( 5666 hom. )

Consequence

NPHS1
NM_004646.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.07
Variant links:
Genes affected
NPHS1 (HGNC:7908): (NPHS1 adhesion molecule, nephrin) This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 19-35843517-G-A is Benign according to our data. Variant chr19-35843517-G-A is described in ClinVar as [Benign]. Clinvar id is 259489.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-35843517-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NPHS1NM_004646.4 linkuse as main transcriptc.2289C>T p.Val763= synonymous_variant 17/29 ENST00000378910.10 NP_004637.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NPHS1ENST00000378910.10 linkuse as main transcriptc.2289C>T p.Val763= synonymous_variant 17/291 NM_004646.4 ENSP00000368190 P2O60500-1
NPHS1ENST00000585400.1 linkuse as main transcriptn.980C>T non_coding_transcript_exon_variant 3/31
NPHS1ENST00000353632.6 linkuse as main transcriptc.2289C>T p.Val763= synonymous_variant 17/285 ENSP00000343634 A2O60500-2

Frequencies

GnomAD3 genomes
AF:
0.161
AC:
24457
AN:
152026
Hom.:
4509
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.455
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0771
Gnomad ASJ
AF:
0.0651
Gnomad EAS
AF:
0.152
Gnomad SAS
AF:
0.0713
Gnomad FIN
AF:
0.0411
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0349
Gnomad OTH
AF:
0.122
GnomAD3 exomes
AF:
0.0788
AC:
19829
AN:
251486
Hom.:
2196
AF XY:
0.0717
AC XY:
9742
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.461
Gnomad AMR exome
AF:
0.0372
Gnomad ASJ exome
AF:
0.0728
Gnomad EAS exome
AF:
0.154
Gnomad SAS exome
AF:
0.0695
Gnomad FIN exome
AF:
0.0419
Gnomad NFE exome
AF:
0.0359
Gnomad OTH exome
AF:
0.0594
GnomAD4 exome
AF:
0.0533
AC:
77898
AN:
1461746
Hom.:
5666
Cov.:
32
AF XY:
0.0523
AC XY:
38011
AN XY:
727186
show subpopulations
Gnomad4 AFR exome
AF:
0.467
Gnomad4 AMR exome
AF:
0.0431
Gnomad4 ASJ exome
AF:
0.0715
Gnomad4 EAS exome
AF:
0.168
Gnomad4 SAS exome
AF:
0.0681
Gnomad4 FIN exome
AF:
0.0431
Gnomad4 NFE exome
AF:
0.0348
Gnomad4 OTH exome
AF:
0.0732
GnomAD4 genome
AF:
0.161
AC:
24533
AN:
152144
Hom.:
4540
Cov.:
32
AF XY:
0.158
AC XY:
11740
AN XY:
74396
show subpopulations
Gnomad4 AFR
AF:
0.455
Gnomad4 AMR
AF:
0.0770
Gnomad4 ASJ
AF:
0.0651
Gnomad4 EAS
AF:
0.151
Gnomad4 SAS
AF:
0.0712
Gnomad4 FIN
AF:
0.0411
Gnomad4 NFE
AF:
0.0350
Gnomad4 OTH
AF:
0.120
Alfa
AF:
0.0503
Hom.:
600
Bravo
AF:
0.178
Asia WGS
AF:
0.121
AC:
422
AN:
3478
EpiCase
AF:
0.0349
EpiControl
AF:
0.0414

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Finnish congenital nephrotic syndrome Benign:5
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtOct 10, 2014- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJun 10, 2021- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 28, 2017- -
not provided Benign:4
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 31, 2016Variant summary: The NPHS1 c.2289C>T (p.Val763Val) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 10368/121400 control chromosomes (1310 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.4543533 (4728/10406). This frequency is about 135 times the estimated maximal expected allele frequency of a pathogenic NPHS1 variant (0.0033541), suggesting this is a benign common polymorphism found primarily in the populations of African origin. Therefore, this variant is classified as Benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Congenital nephrotic syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
4.2
DANN
Benign
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs437168; hg19: chr19-36334419; COSMIC: COSV62286972; COSMIC: COSV62286972; API